Trial Details

COMPLETED
Basic Information
Clinical ID c1330
Identifier NCT05831670
Trial Title An Early Phase 2 Clinical Study of KSP-0243
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Colitis, Ulcerative
Interventions DRUG: KSP-0243|DRUG: Placebo
Participant Information
Sponsor Kissei Pharmaceutical Co., Ltd.
City Multiple Locations
Country/Region Japan
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2023-04-27
Primary Completion Date 2024-10-18
Completion Date 2024-10-18